US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Phio Pharmaceuticals

0.9201

+0.06337.39%

Post-market: 0.92010.00000.00%18:44 EST

Volume:123.56K

Turnover:110.63K

Market Cap:9.90M

PE:-0.43

High:0.9299

Open:0.8400

Low:0.8400

Close:0.8568

52wk High:4.19

52wk Low:0.8127

Shares:10.76M

Float Shares:10.71M

Volume Ratio:0.43

T/O Rate:1.15%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1500

EPS(LYR):-9.0798

ROE:-107.58%

ROA:-60.16%

PB:1.01

PE(LYR):-0.10

Loading ...

Overview Company News Filings

Phio Pharmaceuticals to Present at DealFlow Discovery Conference in Atlantic City

Buy Rating on Phio Pharmaceuticals: Early PH-762 Efficacy, Clean Safety Profile, and Solid Cash Runway Support Favorable Risk–Reward

Phio Pharmaceuticals Corp - Announces Key Tumor Response Data From Ph-762 Trial - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals Corp - Favorable Safety and Tolerability at All Dose Escalations - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals Corp: Safety Data Through Extended Follow-up Period Is Expected to Be Reported in Q2 of 2026

THOMSON REUTERS

Phio Pharmaceuticals Reports 70% Response Rate in PH-762 Skin Cancer Trial

Phio Pharmaceuticals Showcases INTASYL siRNA Cancer Therapy at Sidoti Micro-Cap Virtual Investor Conference

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares

Phio Pharmaceuticals Corp - No Dose-Limiting Toxicities in Ph-762 Trial - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals Corp - Ph-762 Has Been Well Tolerated in All Enrolled Patients in Each Escalating Dose Cohort

THOMSON REUTERS

Phio Pharmaceuticals Corp - Initiatives Continuing to Advance Delivery of Commercially Viable Drug Product in 2026

THOMSON REUTERS

Phio Pharmaceuticals Announces FDA Acceptance of Nonclinical Study Design for PH-762

Phio Pharmaceuticals Completes Enrollment for PH-762 Trial

Phio Pharmaceuticals Completes Phase 1b Enrollment for PH-762 Skin Cancer Trial

Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares

BRIEF-Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing

Phio Pharmaceuticals files to sell 11.76M shares of common stock for holders

Phio Pharmaceuticals Corp Files for Offering of up to 11.8 Mln Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Phio Pharmaceuticals CEO Robert J. Bitterman Acquires Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PHIO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PHIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","market":"US","secType":"STK","nameCN":"Phio Pharmaceuticals","latestPrice":0.9201,"timestamp":1770411600000,"preClose":0.8568,"halted":0,"volume":123558,"hourTrading":{"tag":"盘后","latestPrice":0.9201,"preClose":0.9201,"latestTime":"18:44 EST","volume":36,"amount":32.5624,"timestamp":1770421496015,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.07387955182072832,"floatShares":10714600,"shares":10764400,"eps":-2.15,"marketStatus":"Market Closed","change":0.0633,"latestTime":"02-06 16:00:00 EST","open":0.84,"high":0.9299,"low":0.84,"amount":110632.2701913,"amplitude":0.104925,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.15,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.8568,"preHourTrading":{"tag":"盘前","latestPrice":0.8568,"preClose":0.8568,"latestTime":"09:27 EST","volume":22,"amount":19.0810004,"timestamp":1770388041954,"change":0,"changeRate":0,"amplitude":0.135037},"postHourTrading":{"tag":"盘后","latestPrice":0.9201,"preClose":0.9201,"latestTime":"18:44 EST","volume":36,"amount":32.5624,"timestamp":1770421496015,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4290795336930276,"impliedVol":2.2612,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PHIO\",,,,,undefined,":{"symbol":"PHIO","floatShares":10714600,"roa":"-60.16%","roe":"-107.58%","lyrEps":-9.079757,"volumeRatio":0.4290795336930276,"shares":10764400,"dividePrice":0,"high":0.9299,"amplitude":0.104925,"preClose":0.8568,"low":0.84,"week52Low":0.8127,"pbRate":"1.01","week52High":4.1899,"institutionHeld":0,"latestPrice":0.9201,"eps":-2.15,"divideRate":0,"volume":123558,"delay":0,"ttmEps":-2.15,"open":0.84,"prevYearClose":1.05,"prevWeekClose":1.01,"prevMonthClose":1.01,"prevQuarterClose":1.05,"fiveDayClose":1.01,"twentyDayClose":1.19,"sixtyDayClose":1.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PHIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"PHIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.44},{"market":"US","date":"2025-08-14","symbol":"PHIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-05-15","symbol":"PHIO","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2025-03-31","symbol":"PHIO","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"PHIO","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-1.54}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PHIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PHIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1740027600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PHIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PHIO","date":"2026-02-05","current":-0.427953,"percent":0.34202,"low":-5.606854,"twenty":-1.738251,"median":-0.776088,"eighty":-0.326811,"high":-0.115258,"avg":-1.122338,"sd":1.009323,"marketCap":9957095},"quantilePoints":[{"date":"2021-02-12","current":-3.891489,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":34992269},{"date":"2021-02-19","current":-5.385349,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":48425057},{"date":"2021-02-26","current":-3.959408,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":35602998},{"date":"2021-03-05","current":-3.502553,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31494960},{"date":"2021-03-12","current":-4.360887,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":39213092},{"date":"2021-03-19","current":-4.180913,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37594774},{"date":"2021-03-26","current":-4.323942,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":38024743},{"date":"2021-04-01","current":-4.231616,"twenty":-1.498507,"median":-1.170071,"eighty":-0.754259,"marketCap":37212827},{"date":"2021-04-09","current":-4.216228,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":37077508},{"date":"2021-04-16","current":-3.523782,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":30988135},{"date":"2021-04-23","current":-3.585332,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31529413},{"date":"2021-04-30","current":-3.5552,"twenty":-1.497101,"median":-1.169531,"eighty":-0.754151,"marketCap":31264430},{"date":"2021-05-07","current":-4.109257,"twenty":-1.498848,"median":-1.169531,"eighty":-0.754151,"marketCap":36136808},{"date":"2021-05-14","current":-2.624434,"twenty":-1.499955,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-05-21","current":-2.926725,"twenty":-1.501287,"median":-1.169531,"eighty":-0.754151,"marketCap":28828240},{"date":"2021-05-28","current":-3.050389,"twenty":-1.503829,"median":-1.169531,"eighty":-0.754151,"marketCap":30046334},{"date":"2021-06-04","current":-2.844282,"twenty":-1.504533,"median":-1.169531,"eighty":-0.754151,"marketCap":28016176},{"date":"2021-06-11","current":-3.036649,"twenty":-1.506728,"median":-1.169531,"eighty":-0.754151,"marketCap":29910991},{"date":"2021-06-18","current":-3.022908,"twenty":-1.511311,"median":-1.169531,"eighty":-0.754151,"marketCap":29775647},{"date":"2021-06-25","current":-3.325199,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":32753212},{"date":"2021-07-02","current":-2.967946,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":29234272},{"date":"2021-07-09","current":-2.858022,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":28151520},{"date":"2021-07-16","current":-2.50077,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24632580},{"date":"2021-07-23","current":-2.583213,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25444644},{"date":"2021-07-30","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-06","current":-2.473289,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":24361893},{"date":"2021-08-13","current":-2.142581,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":23279142},{"date":"2021-08-20","current":-2.10521,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":22873111},{"date":"2021-08-27","current":-2.379261,"twenty":-1.512072,"median":-1.169531,"eighty":-0.754151,"marketCap":25850675},{"date":"2021-09-03","current":-2.528744,"twenty":-1.513652,"median":-1.169531,"eighty":-0.754151,"marketCap":27474801},{"date":"2021-09-10","current":-2.553658,"twenty":-1.517656,"median":-1.169531,"eighty":-0.754151,"marketCap":27745489},{"date":"2021-09-17","current":-2.840165,"twenty":-1.535231,"median":-1.169531,"eighty":-0.754151,"marketCap":30858397},{"date":"2021-09-24","current":-2.678226,"twenty":-1.55235,"median":-1.169531,"eighty":-0.754151,"marketCap":29098928},{"date":"2021-10-01","current":-2.478916,"twenty":-1.568375,"median":-1.169531,"eighty":-0.754151,"marketCap":26933426},{"date":"2021-10-08","current":-2.279606,"twenty":-1.575639,"median":-1.177333,"eighty":-0.754151,"marketCap":24767924},{"date":"2021-10-15","current":-2.080297,"twenty":-1.592553,"median":-1.179943,"eighty":-0.754151,"marketCap":22602423},{"date":"2021-10-22","current":-2.030469,"twenty":-1.605485,"median":-1.187834,"eighty":-0.757627,"marketCap":22061047},{"date":"2021-10-29","current":-2.092754,"twenty":-1.626655,"median":-1.191091,"eighty":-0.757651,"marketCap":22737767},{"date":"2021-11-05","current":-2.130124,"twenty":-1.639611,"median":-1.196448,"eighty":-0.757891,"marketCap":23143798},{"date":"2021-11-12","current":-1.727879,"twenty":-1.652657,"median":-1.202967,"eighty":-0.759558,"marketCap":21249455},{"date":"2021-11-19","current":-1.507767,"twenty":-1.654895,"median":-1.210405,"eighty":-0.760343,"marketCap":18542518},{"date":"2021-11-26","current":-1.529778,"twenty":-1.652657,"median":-1.212029,"eighty":-0.760343,"marketCap":18813211},{"date":"2021-12-03","current":-1.298661,"twenty":-1.652657,"median":-1.2135,"eighty":-0.760343,"marketCap":15970928},{"date":"2021-12-10","current":-1.353689,"twenty":-1.652657,"median":-1.217439,"eighty":-0.760343,"marketCap":16647662},{"date":"2021-12-17","current":-1.287655,"twenty":-1.652657,"median":-1.227086,"eighty":-0.761524,"marketCap":15835581},{"date":"2021-12-23","current":-1.298661,"twenty":-1.652657,"median":-1.228561,"eighty":-0.763642,"marketCap":15970928},{"date":"2021-12-31","current":-1.10056,"twenty":-1.652657,"median":-1.228561,"eighty":-0.77102,"marketCap":13534684},{"date":"2022-01-07","current":-1.063471,"twenty":-1.652486,"median":-1.228561,"eighty":-0.771783,"marketCap":13078565},{"date":"2022-01-14","current":-0.973005,"twenty":-1.652486,"median":-1.228561,"eighty":-0.773446,"marketCap":11966015},{"date":"2022-01-21","current":-0.946812,"twenty":-1.652486,"median":-1.228561,"eighty":-0.776821,"marketCap":11643889},{"date":"2022-01-28","current":-0.871643,"twenty":-1.652486,"median":-1.228561,"eighty":-0.781639,"marketCap":10719469},{"date":"2022-02-04","current":-0.985881,"twenty":-1.652486,"median":-1.228561,"eighty":-0.784351,"marketCap":12124370},{"date":"2022-02-11","current":-0.986432,"twenty":-1.652316,"median":-1.228561,"eighty":-0.78546,"marketCap":12131138},{"date":"2022-02-18","current":-0.917427,"twenty":-1.652316,"median":-1.228561,"eighty":-0.790609,"marketCap":11282513},{"date":"2022-02-25","current":-0.928542,"twenty":-1.652316,"median":-1.228561,"eighty":-0.794492,"marketCap":11419214},{"date":"2022-03-04","current":-0.891013,"twenty":-1.652316,"median":-1.228561,"eighty":-0.797055,"marketCap":10957680},{"date":"2022-03-11","current":-0.847211,"twenty":-1.652316,"median":-1.228561,"eighty":-0.798197,"marketCap":10419000},{"date":"2022-03-18","current":-0.934375,"twenty":-1.652316,"median":-1.228561,"eighty":-0.802126,"marketCap":11490947},{"date":"2022-03-25","current":-0.921076,"twenty":-1.652316,"median":-1.228561,"eighty":-0.806184,"marketCap":12238333},{"date":"2022-04-01","current":-0.890312,"twenty":-1.646585,"median":-1.228151,"eighty":-0.808371,"marketCap":11829577},{"date":"2022-04-08","current":-2.39386,"twenty":-1.639396,"median":-1.224535,"eighty":-0.808371,"marketCap":31807215},{"date":"2022-04-14","current":-1.21221,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":16106631},{"date":"2022-04-22","current":-1.283516,"twenty":-1.639396,"median":-1.220432,"eighty":-0.808371,"marketCap":17054081},{"date":"2022-04-29","current":-0.855881,"twenty":-1.639396,"median":-1.214647,"eighty":-0.808371,"marketCap":11372094},{"date":"2022-05-06","current":-0.870346,"twenty":-1.639396,"median":-1.212174,"eighty":-0.808371,"marketCap":11564291},{"date":"2022-05-13","current":-0.771725,"twenty":-1.639396,"median":-1.212137,"eighty":-0.803488,"marketCap":9663542},{"date":"2022-05-20","current":-0.723513,"twenty":-1.639396,"median":-1.206863,"eighty":-0.801113,"marketCap":9059827},{"date":"2022-05-27","current":-0.796268,"twenty":-1.639396,"median":-1.201104,"eighty":-0.797537,"marketCap":9970863},{"date":"2022-06-03","current":-0.839026,"twenty":-1.639396,"median":-1.198734,"eighty":-0.797167,"marketCap":10506284},{"date":"2022-06-10","current":-0.780888,"twenty":-1.639396,"median":-1.193559,"eighty":-0.796536,"marketCap":9778275},{"date":"2022-06-17","current":-0.729621,"twenty":-1.639396,"median":-1.184786,"eighty":-0.793918,"marketCap":9136315},{"date":"2022-06-24","current":-0.740965,"twenty":-1.639504,"median":-1.17781,"eighty":-0.790818,"marketCap":9278366},{"date":"2022-07-01","current":-0.767253,"twenty":-1.639504,"median":-1.17061,"eighty":-0.788511,"marketCap":9607541},{"date":"2022-07-08","current":-0.801831,"twenty":-1.639504,"median":-1.167786,"eighty":-0.787642,"marketCap":10040522},{"date":"2022-07-15","current":-0.771399,"twenty":-1.639504,"median":-1.158325,"eighty":-0.786964,"marketCap":9659458},{"date":"2022-07-22","current":-0.784051,"twenty":-1.639504,"median":-1.151485,"eighty":-0.78508,"marketCap":9817885},{"date":"2022-07-29","current":-0.780015,"twenty":-1.639504,"median":-1.145238,"eighty":-0.783179,"marketCap":9767348},{"date":"2022-08-05","current":-0.785578,"twenty":-1.639504,"median":-1.142726,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-12","current":-0.817469,"twenty":-1.639504,"median":-1.133577,"eighty":-0.781191,"marketCap":10108816},{"date":"2022-08-19","current":-0.795488,"twenty":-1.639504,"median":-1.124069,"eighty":-0.781191,"marketCap":9837007},{"date":"2022-08-26","current":-0.763346,"twenty":-1.639504,"median":-1.118863,"eighty":-0.778622,"marketCap":9439539},{"date":"2022-09-02","current":-0.760806,"twenty":-1.639504,"median":-1.112659,"eighty":-0.776493,"marketCap":9408124},{"date":"2022-09-09","current":-0.793831,"twenty":-1.639504,"median":-1.110534,"eighty":-0.775608,"marketCap":9816519},{"date":"2022-09-16","current":-0.751086,"twenty":-1.639504,"median":-1.101669,"eighty":-0.77548,"marketCap":9287927},{"date":"2022-09-23","current":-0.678959,"twenty":-1.639504,"median":-1.09706,"eighty":-0.773926,"marketCap":8396012},{"date":"2022-09-30","current":-0.631022,"twenty":-1.639504,"median":-1.091535,"eighty":-0.773184,"marketCap":7803224},{"date":"2022-10-07","current":-0.613019,"twenty":-1.639504,"median":-1.084943,"eighty":-0.772177,"marketCap":7580587},{"date":"2022-10-14","current":-0.61578,"twenty":-1.639504,"median":-1.078622,"eighty":-0.771783,"marketCap":7614734},{"date":"2022-10-21","current":-0.641847,"twenty":-1.639504,"median":-1.066994,"eighty":-0.771127,"marketCap":7937079},{"date":"2022-10-28","current":-0.646376,"twenty":-1.639504,"median":-1.055575,"eighty":-0.767034,"marketCap":7993080},{"date":"2022-11-04","current":-0.619646,"twenty":-1.639504,"median":-1.037137,"eighty":-0.763737,"marketCap":7662539},{"date":"2022-11-11","current":-0.53798,"twenty":-1.639504,"median":-1.032527,"eighty":-0.7629,"marketCap":6563358},{"date":"2022-11-18","current":-0.44813,"twenty":-1.639504,"median":-1.023521,"eighty":-0.761465,"marketCap":5467186},{"date":"2022-11-25","current":-0.45362,"twenty":-1.639504,"median":-1.020329,"eighty":-0.759288,"marketCap":5534159},{"date":"2022-12-02","current":-0.445105,"twenty":-1.631759,"median":-1.011325,"eighty":-0.755853,"marketCap":5430283},{"date":"2022-12-09","current":-0.439027,"twenty":-1.631759,"median":-0.999192,"eighty":-0.753074,"marketCap":5356134},{"date":"2022-12-16","current":-0.426844,"twenty":-1.631759,"median":-0.992495,"eighty":-0.75098,"marketCap":5207495},{"date":"2022-12-23","current":-0.401525,"twenty":-1.631759,"median":-0.985881,"eighty":-0.747725,"marketCap":4898599},{"date":"2022-12-30","current":-0.416761,"twenty":-1.631759,"median":-0.979938,"eighty":-0.745379,"marketCap":5084483},{"date":"2023-01-06","current":-0.683398,"twenty":-1.631759,"median":-0.977213,"eighty":-0.742198,"marketCap":8337460},{"date":"2023-01-13","current":-0.60363,"twenty":-1.631759,"median":-0.977213,"eighty":-0.740355,"marketCap":7364287},{"date":"2023-01-20","current":-0.592652,"twenty":-1.631759,"median":-0.977213,"eighty":-0.737547,"marketCap":7230355},{"date":"2023-01-27","current":-0.581635,"twenty":-1.631759,"median":-0.977213,"eighty":-0.734106,"marketCap":7095951},{"date":"2023-02-03","current":-0.616179,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":7517380},{"date":"2023-02-10","current":-0.515331,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6287035},{"date":"2023-02-17","current":-0.489209,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5968344},{"date":"2023-02-24","current":-0.480806,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":5865834},{"date":"2023-03-03","current":-0.560162,"twenty":-1.631759,"median":-0.977213,"eighty":-0.729024,"marketCap":6833982},{"date":"2023-03-10","current":-0.516031,"twenty":-1.631759,"median":-0.977213,"eighty":-0.728426,"marketCap":6295578},{"date":"2023-03-17","current":-0.535889,"twenty":-1.631759,"median":-0.977068,"eighty":-0.726171,"marketCap":6537842},{"date":"2023-03-24","current":-0.572334,"twenty":-1.631759,"median":-0.977068,"eighty":-0.71795,"marketCap":6570398},{"date":"2023-03-31","current":-0.563264,"twenty":-1.629249,"median":-0.975604,"eighty":-0.717167,"marketCap":6466270},{"date":"2023-04-06","current":-0.5793,"twenty":-1.629249,"median":-0.975604,"eighty":-0.714469,"marketCap":6650363},{"date":"2023-04-14","current":-0.505134,"twenty":-1.631759,"median":-0.973005,"eighty":-0.711472,"marketCap":5798933},{"date":"2023-04-21","current":-0.539966,"twenty":-1.631759,"median":-0.973005,"eighty":-0.704091,"marketCap":6198807},{"date":"2023-04-28","current":-0.423323,"twenty":-1.631759,"median":-0.973005,"eighty":-0.701367,"marketCap":4859744},{"date":"2023-05-05","current":-0.509822,"twenty":-1.631759,"median":-0.973005,"eighty":-0.697146,"marketCap":5852757},{"date":"2023-05-12","current":-0.510477,"twenty":-1.631759,"median":-0.9686,"eighty":-0.690766,"marketCap":5860280},{"date":"2023-05-19","current":-0.610776,"twenty":-1.631759,"median":-0.967994,"eighty":-0.681773,"marketCap":7598053},{"date":"2023-05-26","current":-0.454756,"twenty":-1.631759,"median":-0.965521,"eighty":-0.67868,"marketCap":5657164},{"date":"2023-06-02","current":-0.408797,"twenty":-1.631759,"median":-0.96266,"eighty":-0.676522,"marketCap":5085429},{"date":"2023-06-09","current":-0.431758,"twenty":-1.631759,"median":-0.958147,"eighty":-0.664276,"marketCap":5371071},{"date":"2023-06-16","current":-0.456909,"twenty":-1.631759,"median":-0.954712,"eighty":-0.657282,"marketCap":5683949},{"date":"2023-06-23","current":-0.419183,"twenty":-1.634269,"median":-0.944146,"eighty":-0.654729,"marketCap":5214633},{"date":"2023-06-30","current":-0.392634,"twenty":-1.636779,"median":-0.938527,"eighty":-0.648646,"marketCap":4884372},{"date":"2023-07-07","current":-0.419183,"twenty":-1.636779,"median":-0.938527,"eighty":-0.644655,"marketCap":5214633},{"date":"2023-07-14","current":-0.38984,"twenty":-1.636779,"median":-0.937013,"eighty":-0.639638,"marketCap":4849608},{"date":"2023-07-21","current":-0.370977,"twenty":-1.636779,"median":-0.937013,"eighty":-0.633655,"marketCap":4614950},{"date":"2023-07-28","current":-0.375867,"twenty":-1.636779,"median":-0.937013,"eighty":-0.631022,"marketCap":4675787},{"date":"2023-08-04","current":-0.353511,"twenty":-1.639289,"median":-0.93777,"eighty":-0.629587,"marketCap":4397673},{"date":"2023-08-11","current":-0.318579,"twenty":-1.639289,"median":-0.93777,"eighty":-0.624064,"marketCap":3963121},{"date":"2023-08-18","current":-0.406633,"twenty":-1.639289,"median":-0.93777,"eighty":-0.621893,"marketCap":5065831},{"date":"2023-08-25","current":-0.413767,"twenty":-1.639289,"median":-0.93777,"eighty":-0.619457,"marketCap":5154705},{"date":"2023-09-01","current":-0.379881,"twenty":-1.639289,"median":-0.93777,"eighty":-0.610776,"marketCap":4732553},{"date":"2023-09-08","current":-0.401282,"twenty":-1.639396,"median":-0.938527,"eighty":-0.608865,"marketCap":4999176},{"date":"2023-09-15","current":-0.311217,"twenty":-1.639504,"median":-0.939799,"eighty":-0.604931,"marketCap":3877138},{"date":"2023-09-22","current":-0.249687,"twenty":-1.639504,"median":-0.939799,"eighty":-0.602435,"marketCap":3110598},{"date":"2023-09-29","current":-0.262171,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3266128},{"date":"2023-10-06","current":-0.260388,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3243909},{"date":"2023-10-13","current":-0.313892,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3910466},{"date":"2023-10-20","current":-0.244336,"twenty":-1.639504,"median":-0.939799,"eighty":-0.598474,"marketCap":3043942},{"date":"2023-10-27","current":-0.226502,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2821757},{"date":"2023-11-03","current":-0.222578,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2772876},{"date":"2023-11-10","current":-0.181915,"twenty":-1.639826,"median":-0.942079,"eighty":-0.600181,"marketCap":2266293},{"date":"2023-11-17","current":-0.205332,"twenty":-1.639826,"median":-0.942079,"eighty":-0.597918,"marketCap":2394578},{"date":"2023-11-24","current":-0.196951,"twenty":-1.639826,"median":-0.942079,"eighty":-0.591142,"marketCap":2296840},{"date":"2023-12-01","current":-0.229112,"twenty":-1.639826,"median":-0.942079,"eighty":-0.581635,"marketCap":2671909},{"date":"2023-12-08","current":-0.19276,"twenty":-1.639719,"median":-0.941575,"eighty":-0.578835,"marketCap":2247971},{"date":"2023-12-15","current":-0.155046,"twenty":-1.639719,"median":-0.941575,"eighty":-0.573898,"marketCap":1808150},{"date":"2023-12-22","current":-0.16106,"twenty":-1.639719,"median":-0.941575,"eighty":-0.569388,"marketCap":1878277},{"date":"2023-12-29","current":-0.160075,"twenty":-1.639826,"median":-0.942079,"eighty":-0.563264,"marketCap":1866793},{"date":"2024-01-05","current":-0.159656,"twenty":-1.640714,"median":-0.944146,"eighty":-0.559038,"marketCap":1861906},{"date":"2024-01-12","current":-0.146644,"twenty":-1.640714,"median":-0.944146,"eighty":-0.544651,"marketCap":1710168},{"date":"2024-01-19","current":-0.138285,"twenty":-1.641601,"median":-0.946213,"eighty":-0.539172,"marketCap":1612675},{"date":"2024-01-26","current":-0.125713,"twenty":-1.640714,"median":-0.944146,"eighty":-0.534718,"marketCap":1466068},{"date":"2024-02-02","current":-0.127599,"twenty":-1.640714,"median":-0.944146,"eighty":-0.52585,"marketCap":1488059},{"date":"2024-02-09","current":-0.127348,"twenty":-1.640714,"median":-0.944146,"eighty":-0.522459,"marketCap":1485127},{"date":"2024-02-16","current":-0.136189,"twenty":-1.640714,"median":-0.944146,"eighty":-0.51385,"marketCap":1588240},{"date":"2024-02-23","current":-0.178077,"twenty":-1.640714,"median":-0.944146,"eighty":-0.512362,"marketCap":2076736},{"date":"2024-03-01","current":-0.226284,"twenty":-1.639826,"median":-0.942079,"eighty":-0.508511,"marketCap":2638922},{"date":"2024-03-08","current":-0.184798,"twenty":-1.639826,"median":-0.942079,"eighty":-0.503269,"marketCap":2155120},{"date":"2024-03-15","current":-0.197244,"twenty":-1.639826,"median":-0.935928,"eighty":-0.492183,"marketCap":2300261},{"date":"2024-03-22","current":-0.175999,"twenty":-1.639826,"median":-0.928542,"eighty":-0.488621,"marketCap":2052495},{"date":"2024-03-28","current":-0.152134,"twenty":-1.639826,"median":-0.921076,"eighty":-0.486408,"marketCap":1774186},{"date":"2024-04-05","current":-0.156456,"twenty":-1.640714,"median":-0.916562,"eighty":-0.480806,"marketCap":1693797},{"date":"2024-04-12","current":-0.296683,"twenty":-1.640714,"median":-0.91096,"eighty":-0.469768,"marketCap":3211894},{"date":"2024-04-19","current":-0.270514,"twenty":-1.640714,"median":-0.906077,"eighty":-0.458759,"marketCap":2928586},{"date":"2024-04-26","current":-0.29944,"twenty":-1.639826,"median":-0.902569,"eighty":-0.45362,"marketCap":3241740},{"date":"2024-05-03","current":-0.329002,"twenty":-1.639826,"median":-0.896424,"eighty":-0.44813,"marketCap":3561781},{"date":"2024-05-10","current":-0.326585,"twenty":-1.639826,"median":-0.890312,"eighty":-0.445105,"marketCap":3535609},{"date":"2024-05-17","current":-0.358601,"twenty":-1.639826,"median":-0.880558,"eighty":-0.440142,"marketCap":3362961},{"date":"2024-05-24","current":-0.375934,"twenty":-1.639826,"median":-0.869368,"eighty":-0.436591,"marketCap":3525507},{"date":"2024-05-31","current":-0.368247,"twenty":-1.639826,"median":-0.863934,"eighty":-0.431758,"marketCap":3453417},{"date":"2024-06-07","current":-0.367218,"twenty":-1.639826,"median":-0.848175,"eighty":-0.425948,"marketCap":3443775},{"date":"2024-06-14","current":-0.357426,"twenty":-1.640714,"median":-0.843753,"eighty":-0.421762,"marketCap":3351941},{"date":"2024-06-21","current":-0.349053,"twenty":-1.641601,"median":-0.832901,"eighty":-0.419183,"marketCap":3273422},{"date":"2024-06-28","current":-0.337449,"twenty":-1.644264,"median":-0.825843,"eighty":-0.417785,"marketCap":3164595},{"date":"2024-07-05","current":-0.284373,"twenty":-1.644264,"median":-0.821822,"eighty":-0.414991,"marketCap":2666854},{"date":"2024-07-12","current":-0.317983,"twenty":-1.644264,"median":-0.816685,"eighty":-0.411983,"marketCap":2982048},{"date":"2024-07-15","current":-0.274733,"twenty":-1.644264,"median":-0.812746,"eighty":-0.410799,"marketCap":2576449},{"date":"2024-08-02","current":-0.161304,"twenty":-1.655347,"median":-0.803629,"eighty":-0.407754,"marketCap":1512707},{"date":"2024-08-09","current":-0.143079,"twenty":-1.655347,"median":-0.80079,"eighty":-0.40521,"marketCap":1341794},{"date":"2024-08-16","current":-0.151733,"twenty":-1.655347,"median":-0.798197,"eighty":-0.402675,"marketCap":1316285},{"date":"2024-08-23","current":-0.303609,"twenty":-1.655347,"median":-0.796603,"eighty":-0.395988,"marketCap":2633806},{"date":"2024-08-30","current":-0.261937,"twenty":-1.655347,"median":-0.793831,"eighty":-0.391029,"marketCap":2272303},{"date":"2024-09-06","current":-0.260945,"twenty":-1.655347,"median":-0.789855,"eighty":-0.385648,"marketCap":2263696},{"date":"2024-09-13","current":-0.287734,"twenty":-1.655347,"median":-0.786887,"eighty":-0.381456,"marketCap":2496090},{"date":"2024-09-20","current":-0.352226,"twenty":-1.655347,"median":-0.781191,"eighty":-0.37873,"marketCap":3055559},{"date":"2024-09-27","current":-0.35421,"twenty":-1.655347,"median":-0.779362,"eighty":-0.374682,"marketCap":3072773},{"date":"2024-10-04","current":-0.313531,"twenty":-1.655347,"median":-0.775543,"eighty":-0.372417,"marketCap":2719878},{"date":"2024-10-11","current":-0.253007,"twenty":-1.655347,"median":-0.773907,"eighty":-0.36763,"marketCap":2194838},{"date":"2024-10-18","current":-0.262929,"twenty":-1.655347,"median":-0.773508,"eighty":-0.363792,"marketCap":2280910},{"date":"2024-10-25","current":-0.293687,"twenty":-1.655347,"median":-0.773177,"eighty":-0.357426,"marketCap":2547734},{"date":"2024-10-31","current":-0.312538,"twenty":-1.655347,"median":-0.772052,"eighty":-0.353511,"marketCap":2711271},{"date":"2024-11-08","current":-0.32246,"twenty":-1.65613,"median":-0.770744,"eighty":-0.35155,"marketCap":2797343},{"date":"2024-11-15","current":-0.221257,"twenty":-1.65613,"median":-0.76436,"eighty":-0.347708,"marketCap":1919407},{"date":"2024-11-22","current":-0.29352,"twenty":-1.65613,"median":-0.76436,"eighty":-0.344977,"marketCap":2177624},{"date":"2024-11-29","current":-0.386871,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2870195},{"date":"2024-12-06","current":-0.385449,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":2859643},{"date":"2024-12-13","current":-0.408362,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339518,"marketCap":3029639},{"date":"2024-12-20","current":-0.247484,"twenty":-1.65613,"median":-0.76436,"eighty":-0.339311,"marketCap":1836081},{"date":"2024-12-27","current":-0.297265,"twenty":-1.65613,"median":-0.76436,"eighty":-0.337364,"marketCap":2205407},{"date":"2025-01-03","current":-0.270241,"twenty":-1.65613,"median":-0.763489,"eighty":-0.332534,"marketCap":2004916},{"date":"2025-01-10","current":-0.240372,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326962,"marketCap":1783320},{"date":"2025-01-17","current":-0.831105,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6165966},{"date":"2025-01-24","current":-0.881902,"twenty":-1.656913,"median":-0.760806,"eighty":-0.326585,"marketCap":6542829},{"date":"2025-01-31","current":-0.836676,"twenty":-1.656913,"median":-0.7613,"eighty":-0.326585,"marketCap":6207299},{"date":"2025-02-07","current":-0.931978,"twenty":-1.656913,"median":-0.762021,"eighty":-0.326585,"marketCap":6914344},{"date":"2025-02-14","current":-0.821793,"twenty":-1.656913,"median":-0.763435,"eighty":-0.326962,"marketCap":6096884},{"date":"2025-02-21","current":-0.789656,"twenty":-1.656913,"median":-0.765835,"eighty":-0.326962,"marketCap":5858459},{"date":"2025-02-28","current":-0.920729,"twenty":-1.656913,"median":-0.768837,"eighty":-0.326962,"marketCap":6830892},{"date":"2025-03-07","current":-0.862782,"twenty":-1.657245,"median":-0.771897,"eighty":-0.326887,"marketCap":6400976},{"date":"2025-03-14","current":-0.856343,"twenty":-1.657245,"median":-0.773343,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-21","current":-0.856343,"twenty":-1.657245,"median":-0.775465,"eighty":-0.326887,"marketCap":6353207},{"date":"2025-03-28","current":-0.843465,"twenty":-1.657245,"median":-0.777869,"eighty":-0.326887,"marketCap":6257670},{"date":"2025-04-04","current":-0.781666,"twenty":-1.657245,"median":-0.779906,"eighty":-0.326887,"marketCap":5588912},{"date":"2025-04-11","current":-1.102651,"twenty":-1.656913,"median":-0.776375,"eighty":-0.326962,"marketCap":7883954},{"date":"2025-04-17","current":-1.804338,"twenty":-1.658575,"median":-0.776375,"eighty":-0.326962,"marketCap":12901015},{"date":"2025-04-25","current":-1.490249,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":10655283},{"date":"2025-05-02","current":-1.263037,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9030711},{"date":"2025-05-09","current":-1.202892,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8600677},{"date":"2025-05-16","current":-1.189526,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8505114},{"date":"2025-05-23","current":-1.299601,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":8791803},{"date":"2025-05-30","current":-1.440862,"twenty":-1.66359,"median":-0.776231,"eighty":-0.326887,"marketCap":9747434},{"date":"2025-06-06","current":-1.73751,"twenty":-1.666289,"median":-0.776231,"eighty":-0.326887,"marketCap":11754258},{"date":"2025-06-13","current":-1.751876,"twenty":-1.679146,"median":-0.776231,"eighty":-0.326887,"marketCap":11851440},{"date":"2025-06-20","current":-1.673857,"twenty":-1.686968,"median":-0.776088,"eighty":-0.326811,"marketCap":11323643},{"date":"2025-06-27","current":-1.567468,"twenty":-1.686968,"median":-0.776088,"eighty":-0.326811,"marketCap":10603920},{"date":"2025-07-03","current":-1.702227,"twenty":-1.691978,"median":-0.776088,"eighty":-0.326811,"marketCap":11515569},{"date":"2025-07-11","current":-1.734144,"twenty":-1.707909,"median":-0.776088,"eighty":-0.326811,"marketCap":11731486},{"date":"2025-07-18","current":-1.723505,"twenty":-1.719261,"median":-0.776088,"eighty":-0.326811,"marketCap":11659514},{"date":"2025-07-25","current":-1.780246,"twenty":-1.733339,"median":-0.776088,"eighty":-0.326811,"marketCap":12043366},{"date":"2025-08-01","current":-1.688042,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":11419606},{"date":"2025-08-08","current":-1.595838,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":10795846},{"date":"2025-08-15","current":-1.553283,"twenty":-1.734773,"median":-0.776088,"eighty":-0.326811,"marketCap":10507957},{"date":"2025-08-22","current":-1.673165,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":11854372},{"date":"2025-08-29","current":-1.600418,"twenty":-1.737582,"median":-0.776088,"eighty":-0.326811,"marketCap":11338965},{"date":"2025-09-05","current":-1.665082,"twenty":-1.737619,"median":-0.77587,"eighty":-0.326736,"marketCap":11797105},{"date":"2025-09-12","current":-1.875238,"twenty":-1.740189,"median":-0.776088,"eighty":-0.326811,"marketCap":13286060},{"date":"2025-09-19","current":-1.705496,"twenty":-1.748297,"median":-0.776088,"eighty":-0.326811,"marketCap":12083442},{"date":"2025-09-26","current":-1.778243,"twenty":-1.758968,"median":-0.776088,"eighty":-0.326811,"marketCap":12598850},{"date":"2025-10-03","current":-1.931818,"twenty":-1.768898,"median":-0.776088,"eighty":-0.326811,"marketCap":13686932},{"date":"2025-10-10","current":-1.90757,"twenty":-1.784533,"median":-0.776088,"eighty":-0.326811,"marketCap":13515130},{"date":"2025-10-17","current":-1.713579,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":12140710},{"date":"2025-10-24","current":-1.729745,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":12255245},{"date":"2025-10-31","current":-1.665082,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":11797105},{"date":"2025-11-07","current":-1.196272,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":8475590},{"date":"2025-11-14","current":-1.155858,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":8189252},{"date":"2025-11-21","current":-1.610671,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":12809669},{"date":"2025-11-28","current":-1.705417,"twenty":-1.794111,"median":-0.776088,"eighty":-0.326811,"marketCap":13563179},{"date":"2025-12-05","current":-1.827232,"twenty":-1.794418,"median":-0.776088,"eighty":-0.326811,"marketCap":14531977},{"date":"2025-12-12","current":-1.542996,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":12271447},{"date":"2025-12-19","current":-1.434716,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":11410293},{"date":"2025-12-26","current":-1.421181,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":11302649},{"date":"2026-01-02","current":-1.421181,"twenty":-1.789969,"median":-0.776088,"eighty":-0.326811,"marketCap":11302649},{"date":"2026-01-09","current":-1.610671,"twenty":-1.778889,"median":-0.776088,"eighty":-0.326811,"marketCap":12809669},{"date":"2026-01-16","current":-1.529461,"twenty":-1.762077,"median":-0.776088,"eighty":-0.326811,"marketCap":12163803},{"date":"2026-01-23","current":-1.461786,"twenty":-1.755984,"median":-0.776088,"eighty":-0.326811,"marketCap":11625582},{"date":"2026-01-30","current":-1.380575,"twenty":-1.745955,"median":-0.776088,"eighty":-0.326811,"marketCap":10979716},{"date":"2026-02-05","current":-1.251992,"twenty":-1.738251,"median":-0.776088,"eighty":-0.326811,"marketCap":9957095}],"updateTime":1770430748855},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PHIO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606248045","title":"Phio Pharmaceuticals to Present at DealFlow Discovery Conference in Atlantic City","url":"https://stock-news.laohu8.com/highlight/detail?id=2606248045","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606248045?lang=en_us&edition=fundamental","pubTime":"2026-01-26 21:15","pubTimestamp":1769433356,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. will participate in the 3rd Annual DealFlow Discovery Conference, taking place on January 28-29, 2026, at the Borgata Hotel, Casino & Spa in Atlantic City, NJ. CEO and Chairman Robert Bitterman will deliver a company presentation on January 28 at 9 AM ET in Borgata Hotel Room #1. The management team will also be available for one-on-one investor meetings throughout the event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile  on January 26, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL62GP7b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2605108571","title":"Buy Rating on Phio Pharmaceuticals: Early PH-762 Efficacy, Clean Safety Profile, and Solid Cash Runway Support Favorable Risk–Reward","url":"https://stock-news.laohu8.com/highlight/detail?id=2605108571","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605108571?lang=en_us&edition=fundamental","pubTime":"2026-01-21 00:36","pubTimestamp":1768926995,"startTime":"0","endTime":"0","summary":"Analyst Matthew Keller of H.C. Wainwright reiterated a Buy rating on Phio Pharmaceuticals, retaining the price target of $14.00. Matthew Keller has...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-on-phio-pharmaceuticals-early-ph-762-efficacy-clean-safety-profile-and-solid-cash-runway-support-favorable-risk-reward-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-on-phio-pharmaceuticals-early-ph-762-efficacy-clean-safety-profile-and-solid-cash-runway-support-favorable-risk-reward-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PH","PHIO"],"gpt_icon":0},{"id":"2604931111","title":"Phio Pharmaceuticals Corp - Announces Key Tumor Response Data From Ph-762 Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604931111","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604931111?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:33","pubTimestamp":1768919639,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0GE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2604119571","title":"Phio Pharmaceuticals Corp - Favorable Safety and Tolerability at All Dose Escalations - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119571?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:33","pubTimestamp":1768919639,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0GE:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2604111968","title":"Phio Pharmaceuticals Corp: Safety Data Through Extended Follow-up Period Is Expected to Be Reported in Q2 of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111968?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:33","pubTimestamp":1768919639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL0GE:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2604111675","title":"Phio Pharmaceuticals Reports 70% Response Rate in PH-762 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111675","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111675?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:31","pubTimestamp":1768919468,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. has announced key pathology and safety data from its Phase 1b dose escalation clinical trial evaluating the INTASYL compound PH-762 for the treatment of skin cancer. The trial included 22 patients with cutaneous carcinomas across five dose-escalating cohorts. Results indicate a 70% overall response rate for squamous cell carcinomas , with 10 out of 14 responders achieving complete clearance. The treatment was well tolerated, with no dose-limiting toxicities or clinically relevant treatment-emergent adverse effects reported. Safety data from an extended follow-up period is expected to be reported in the second quarter of 2026. The company is proceeding with the design of follow-on clinical trials based on these findings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL634l2G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2603835369","title":"Phio Pharmaceuticals Showcases INTASYL siRNA Cancer Therapy at Sidoti Micro-Cap Virtual Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603835369","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603835369?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:45","pubTimestamp":1768484756,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. will participate in the Sidoti Micro-Cap Virtual Investor Conference on January 21-22, 2026. CEO and Chairman Robert Bitterman is scheduled to present an update on the company's proprietary INTASYL siRNA technology and ongoing clinical trial with lead compound PH-762 for the treatment of skin cancers. The presentation will take place on January 22, 2026, at 1:45 PM ET, and the event will also offer one-on-one meetings with investors throughout both days. Registration is free and open to all interested parties.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via Newsfile  on January 15, 2026, and is solely responsible for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL3dWCn3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2600736098","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2600736098","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600736098?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:06","pubTimestamp":1767387968,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., has reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nNDL2qrg3S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2595780016","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2595780016","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595780016?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:10","pubTimestamp":1767013852,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDLcdV9zB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2593576413","title":"Phio Pharmaceuticals Corp - No Dose-Limiting Toxicities in Ph-762 Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593576413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593576413?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:53","pubTimestamp":1766498016,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0MI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2593413669","title":"Phio Pharmaceuticals Corp - Ph-762 Has Been Well Tolerated in All Enrolled Patients in Each Escalating Dose Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413669?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:53","pubTimestamp":1766498016,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0MI:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2593413501","title":"Phio Pharmaceuticals Corp - Initiatives Continuing to Advance Delivery of Commercially Viable Drug Product in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413501?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:53","pubTimestamp":1766498016,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XT0MI:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2593413393","title":"Phio Pharmaceuticals Announces FDA Acceptance of Nonclinical Study Design for PH-762","url":"https://stock-news.laohu8.com/highlight/detail?id=2593413393","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593413393?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:46","pubTimestamp":1766497587,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. has announced a significant advancement in its drug development program for PH-762. The U.S. Food and Drug Administration  has accepted the design of a nonclinical toxicology study, which is required prior to initiating a human pivotal trial. The study is scheduled to commence in the first quarter of 2026. Additionally, Phio is on track to deliver a commercially viable drug product from its U.S. supplier later in 2026, in compliance with the FDA's current Good Manufacturing Practices. The results of the nonclinical study have not yet been presented, as the study has not yet begun.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL3mh04z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2586401960","title":"Phio Pharmaceuticals Completes Enrollment for PH-762 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586401960","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586401960?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:27","pubTimestamp":1764106057,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals ( ($PHIO) ) has provided an announcement. On November 25, 2025, Phio Pharmaceuticals announced the completion of patient enrol...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/phio-pharmaceuticals-completes-enrollment-for-ph-762-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/phio-pharmaceuticals-completes-enrollment-for-ph-762-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","BK4580","LU1989772923.USD","BK4588","LU0208291251.USD","LU0256863902.USD","LU0256863811.USD","BK4161","BK4139","PH","LU0070302665.USD","LU1989772840.SGD","LU0320765489.SGD","BK4585","LU1988902786.USD","LU2264538146.SGD","LU0211331839.USD","PHIO","LU1064131342.USD"],"gpt_icon":0},{"id":"2586477413","title":"Phio Pharmaceuticals Completes Phase 1b Enrollment for PH-762 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2586477413","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586477413?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:31","pubTimestamp":1764088261,"startTime":"0","endTime":"0","summary":"Phio Pharmaceuticals Corp. has announced the completion of enrollment in its Phase 1b clinical trial of PH-762, an INTASYL siRNA compound designed to silence the PD-1 gene implicated in various forms of skin cancer. The trial is evaluating the safety and tolerability of neoadjuvant intratumoral PH-762 in patients with cutaneous squamous cell carcinoma , melanoma, and Merkel cell carcinoma. To date, 18 patients have completed treatment across five dose-escalating cohorts. Pathology results for the highest dose cohort are expected in Q1 2026. No dose-limiting toxicities or clinically relevant treatment-emergent adverse effects have been observed so far.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL94q63P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2586491199","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491199","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586491199?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:54","pubTimestamp":1764006880,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President, and CEO of Phio Pharmaceuticals Corp., reported the acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL4sJNYr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2585616852","title":"BRIEF-Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585616852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585616852?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:44","pubTimestamp":1763675056,"startTime":"0","endTime":"0","summary":"BRIEF-Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC FilingNov 20  - Phio Pharmaceuticals Corp PHIO.O:PHIO PHARMACEUTICALS CORP FILES FOR OFFERING OF UP TO 11.8 MILLION COMMON SHARES BY THE SELLING STOCKHOLDERS - SEC FILINGFurther company coverage: PHIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PHIO"],"gpt_icon":0},{"id":"2585150601","title":"Phio Pharmaceuticals files to sell 11.76M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2585150601","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585150601?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:11","pubTimestamp":1763673071,"startTime":"0","endTime":"0","summary":"The company will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock. Published first on TheFly...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-files-to-sell-11-76m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/phio-pharmaceuticals-files-to-sell-11-76m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2585761157","title":"Phio Pharmaceuticals Corp Files for Offering of up to 11.8 Mln Common Shares by the Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585761157","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585761157?lang=en_us&edition=fundamental","pubTime":"2025-11-21 05:07","pubTimestamp":1763672830,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nFWN3WW124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PHIO","BK4139"],"gpt_icon":0},{"id":"2584089922","title":"Phio Pharmaceuticals CEO Robert J. Bitterman Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584089922","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584089922?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:48","pubTimestamp":1763574498,"startTime":"0","endTime":"0","summary":"Robert J. Bitterman, Chairman, President & CEO of Phio Pharmaceuticals Corp., reported an acquisition of common shares of Phio Pharmaceuticals Corp. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phio Pharmaceuticals Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDLqVrvh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phio Pharmaceuticals CEO Robert J. Bitterman Acquires Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHIO","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}